The remedy can be applied every two months and is considered to be more effective than current medications for the disease.
The National Agency for Health Surveillance (Anvisa) approved the first injectable HIV drug in Brazil. Medicine is called cabotegravir and is pre-exposure prophylaxis (PrEP). This means that it has a preventive function against possible infections by the virus that causes AIDS.
The authorization for the use of the drug in Brazil was given to the British pharmaceutical company GSK and the report was published in the Official Gazette (DOU) on 5 June. There is still no date for the start of marketing in Brazil.
The medicine was approved in 2021 by the FDA, a regulatory agency in the United States. In 2022, the Oswaldo Cruz Foundation (Fiocruz) started the studies to implement the drug in the Unified Health System (SUS). Currently, the treatment for the virus is done via the Truvada cocktail, which is the combination of Tenofovir and Emtricitabine.
According to the British authorities, the drug approved by Anvisa is more effective against HIV than the pills sold in hospitals. However, the injection will have a prolonged action and medium and long-term effects.
The drug in question is a PrEP; therefore it has a preventive function against possible infections. #Anvisa #HIV #TVCulturehttps://t.co/Ujm6fhiISv
— TVCultura (@tvcultura) June 10, 2023
Source: Terra
Ben Stock is a lifestyle journalist and author at Gossipify. He writes about topics such as health, wellness, travel, food and home decor. He provides practical advice and inspiration to improve well-being, keeps readers up to date with latest lifestyle news and trends, known for his engaging writing style, in-depth analysis and unique perspectives.
![New Day ahead: What awaits you in the 15 Episode of Friday July 18, 2025 [SPOILERS]](https://fr.web.img6.acsta.net/img/be/e7/bee7c3880c14c02baf6e832fe76e123a.jpg "New Day ahead: What awaits you in the 15 Episode of Friday July 18, 2025 [SPOILERS]")
